Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Altasciences Acquires Alliance Contract Pharma | Contract Pharma

What are you searching for?

Sign in
Breaking News

Altasciences Acquires Alliance Contract Pharma

Adds contract manufacturing and analytical services to early phase research offering

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Altasciences, a mid-size CRO, has acquired Alliance Contract Pharma, adding small molecule contract manufacturing and analytical services from API to commercialization, including manufacturing, GMP storage, and clinical supply distribution, to Altasciences’ preclinical, clinical, and bioanalytical offerings.

With the acquisition, Altasciences aims to address the challenges associated with transferring data, projects, and/or methodologies between CROs, which can lead to prolonged R&D timelines.

Through the integration of key strategic additions, such as its preclinical business in October 2018, and now Alliance Contract Pharma, clients can benefit from integrated service offerings for more proactive development timeline adjustments and decision making to improve R&D efficiency.

“The addition of Alliance Contract Pharma continues to fulfill our strategy of creating a comprehensive offering that facilitates the outsourcing experience for our clients. We remain committed to providing our clients with value-added services that create a new paradigm of drug development outsourcing,” added Chris Perkin, CEO of Altasciences.

“We are excited to be joining a team that is responsive and understanding, and continuously looking to create innovative partnerships that redefine the status quo and address the challenges that our clients face in meeting critical milestones,” stated Stephen Schweibenz, President of Alliance Contract Pharma.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics